Core Viewpoint - Beneficient has successfully closed a $1.91 million primary capital commitment for Mendoza Ventures Growth Fund III, LP, marking its third GP Primary transaction of the fiscal year and fourth since the program's launch in late 2024 [1][2][3] Group 1: Transaction Details - The Fund received approximately $1.91 million in shares of Beneficient's Resettable Convertible Preferred Stock, which can be converted into Class A common stock [2] - The transaction is expected to increase the collateral for Beneficient's ExAlt loan portfolio by approximately $1.91 million in interests in alternative assets [2] - Beneficient has entered into a Preferred Liquidity Provider Program Agreement with the Fund to facilitate ongoing liquidity solutions for the Fund and its limited partners [2] Group 2: Strategic Objectives - Beneficient's GP Primary Commitment Program aims to provide primary capital solutions and financing anchor commitments to general partners during fundraising efforts, addressing a potential demand of up to $330 billion for primary commitments [3] - The company is focused on pursuing additional opportunities that align with its strategic vision and growth objectives [3] Group 3: Company Overview - Beneficient is dedicated to democratizing the global alternative asset investment market by offering solutions to traditionally underserved investors, including mid-to-high net worth individuals and small-to-midsized institutions [4] - The company's AltQuote® tool allows customers to explore a range of potential exit options quickly, while the AltAccess® portal provides a secure online environment for proposals and opportunities [4]
Beneficient Enters into $1.91 Million GP Primary Capital Transaction